xmab2513
mAbexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2007 (NCT00606645)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
TNFRSF8 inhibitor
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS33VWC847G8 ↗
- ChEMBLCHEMBL4298133 ↗
Also known as
- xmab2513
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00606645 | Phase 1 | Dec 1, 2007 | University of Texas at Houston, Xencor |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Texas at Houston | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Xencor | For profit | 1 | 1 | 1 | 2007 |
2 organizations
Page 1 / 1